These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 20733041
1. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M. Antimicrob Agents Chemother; 2010 Nov; 54(11):4643-7. PubMed ID: 20733041 [Abstract] [Full Text] [Related]
2. Characteristics of clinical and environmental vanM-carrying vancomycin-resistant enterococci isolates from an infected patient. Zhang G, Lin X, Cai J, Zhang R, Xiu H, Tian B, Cui W. Int J Antimicrob Agents; 2018 Jun; 51(6):932-935. PubMed ID: 29339295 [Abstract] [Full Text] [Related]
3. Genetic characteristics of vancomycin resistance gene cluster in Enterococcus spp. Chen CH, Xu XG. Yi Chuan; 2015 May; 37(5):452-7. PubMed ID: 25998433 [Abstract] [Full Text] [Related]
5. Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes. Marcadé G, Micol JB, Jacquier H, Raskine L, Donay JL, Nicolas-Viaud S, Rouveau M, Ribaud P, Dombret H, Leclercq R, Cambau E. J Antimicrob Chemother; 2014 Feb; 69(2):500-5. PubMed ID: 24092659 [Abstract] [Full Text] [Related]
6. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Depardieu F, Kolbert M, Pruul H, Bell J, Courvalin P. Antimicrob Agents Chemother; 2004 Oct; 48(10):3892-904. PubMed ID: 15388450 [Abstract] [Full Text] [Related]
7. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium. Gargvanshi S, Vemula H, Gutheil WG. J Bacteriol; 2021 Jul 22; 203(16):e0023021. PubMed ID: 34060906 [Abstract] [Full Text] [Related]
8. D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, Leclercq R, Courvalin P, Cattoir V. Antimicrob Agents Chemother; 2011 Oct 22; 55(10):4606-12. PubMed ID: 21807981 [Abstract] [Full Text] [Related]
9. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Arthur M, Depardieu F, Reynolds P, Courvalin P. Mol Microbiol; 1996 Jul 22; 21(1):33-44. PubMed ID: 8843432 [Abstract] [Full Text] [Related]
10. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier]. Godreuil S, Marchandin H, Boulier A, Boumzebra A, Campos J, Jean-Pierre H. Pathol Biol (Paris); 2007 Nov 22; 55(8-9):418-23. PubMed ID: 17905540 [Abstract] [Full Text] [Related]
11. New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains. Depardieu F, Foucault ML, Bell J, Dubouix A, Guibert M, Lavigne JP, Levast M, Courvalin P. Antimicrob Agents Chemother; 2009 May 22; 53(5):1952-63. PubMed ID: 19258279 [Abstract] [Full Text] [Related]
12. A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. Ostrowsky BE, Clark NC, Thauvin-Eliopoulos C, Venkataraman L, Samore MH, Tenover FC, Eliopoulos GM, Moellering RC, Gold HS. J Infect Dis; 1999 Oct 22; 180(4):1177-85. PubMed ID: 10479146 [Abstract] [Full Text] [Related]
14. Characterization of vanM carrying clinical Enterococcus isolates and diversity of the suppressed vanM gene cluster. Sun L, Qu T, Wang D, Chen Y, Fu Y, Yang Q, Yu Y. Infect Genet Evol; 2019 Mar 22; 68():145-152. PubMed ID: 30553064 [Abstract] [Full Text] [Related]
15. Vancomycin heteroresistance caused by unstable tandem amplifications of the vanM gene cluster on linear conjugative plasmids in a clinical Enterococcus faecium. Sun L, Zhuang H, Chen M, Chen Y, Chen Y, Shi K, Yu Y. Antimicrob Agents Chemother; 2024 May 02; 68(5):e0115923. PubMed ID: 38506549 [Abstract] [Full Text] [Related]
16. First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. Panesso D, Ospina S, Robledo J, Vela MC, Peña J, Hernández O, Reyes J, Arias CA. Emerg Infect Dis; 2002 Sep 02; 8(9):961-5. PubMed ID: 12194774 [Abstract] [Full Text] [Related]
17. Real-time PCR for the rapid detection of vanA, vanB and vanM genes. He YH, Ruan GJ, Hao H, Xue F, Ma YK, Zhu SN, Zheng B. J Microbiol Immunol Infect; 2020 Oct 02; 53(5):746-750. PubMed ID: 30926279 [Abstract] [Full Text] [Related]
18. Glycopeptide-resistant enterococci: a decade of experience. Woodford N. J Med Microbiol; 1998 Oct 02; 47(10):849-62. PubMed ID: 9788808 [Abstract] [Full Text] [Related]
19. Clinical and microbiological characteristics of vancomycin-resistant enterococci with the VanD phenotype and vanA genotype. Song JY, Cheong HJ, Seo YB, Kim IS, Heo JY, Noh JY, Choi WS, Kim WJ. Jpn J Infect Dis; 2013 Oct 02; 66(1):1-5. PubMed ID: 23429076 [Abstract] [Full Text] [Related]
20. Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil. Dalla Costa LM, Reynolds PE, Souza HA, Souza DC, Palepou MF, Woodford N. Antimicrob Agents Chemother; 2000 Dec 02; 44(12):3444-6. PubMed ID: 11083656 [Abstract] [Full Text] [Related] Page: [Next] [New Search]